Hrodek O. Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study
Published in:
Transfuze Hematol. dnes,20, 2014, No. 2, p. 86-87.
Category:
Selection of press reports and books
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2014 Issue 2
- Administration of aPCC as a Prevention of Bleeding After Major Cardiac Surgical Procedures
- Cost Effectiveness of FVIII Substitution Versus Non-Factor Therapy for Hemophilia A
- Vascular Disease in the Gradually Aging Population of Hemophiliacs: An Underestimated Problem?
- Prognostic Significance of Subclinical Joint Changes on MRI in Hemophilia
- Immunotolerance is still the goal of management of hemophilia A with inhibitor in the era of non-factor therapy
Most read in this issue
- Chronic myelomonocytic leukemia – a review of present diagnostic and treatment options
- Elimination the risk of hepatitis B virus transfusion-transmitted infection in the phase of possible occult HBV infection
- Evaluation of CD45 antigen expression in patients with multiple myeloma and its effect on time to progression or relapse
- Mechanisms of immune tolerance induction of tumour cells in chronic lymphocytic leukaemia and possibilityof their detection using flow cytometry